Monday, July 22, 2024
Home Stock Analysis Friday frenzy, these stocks are up big today

Friday frenzy, these stocks are up big today

by xyonent
0 comment
Image 1 .png
*Courtesy of GoldMining Inc.

Be sure to set a reminder to join over 1,000 traders in the Market Masters Trading Room for live trading signals and education. We will be streaming Roaring Kitty at 12pm EST today so make sure you tune in!!!


Focus List🔎

Gern – RYTELO™ (Imetelstat) Increases Premarket Sales by More Than 38% Following FDA Approval for the Treatment of Adult Patients with Lower-Risk MDS and Transfusion-Dependent Anemia

BCDA – Prestock shares rise more than 45% after company announces U.S. patent issued for intramyocardial delivery of cell aggregates to the heart, including via a minimally invasive radial artery approach

Vero – Rising more than 100% from the previous day after Nasdaq announced it had restored compliance


*Courtesy of GoldMining Inc.

update: Since we first featured this company on Monday, the company has risen over 10% in the week, so put this stock on your watchlist and read more on our page today 🤿.


In the late 1960s, French President Charles de Gaulle begins to reduce America’s economic influence By reducing France’s US dollar reserves by exchanging them for gold.

This prompted other countries to follow suit, forcing President Nixon to close the “Gold Window,” a promise by the U.S. government to exchange US dollars for gold.

In 10 years, gold rose from $30 to $800, a 2,500% increase in price.

Let’s fast forward to today’s playbook…China continues to buy gold from US reserves (just like European countries did in the 1970s).

And almost as influential is the unprecedented purchase of physical gold by hundreds of millions of Chinese citizens.

Chinese momentum shows no signs of slowing as gold prices surge historic

The only question is: How do you try to take advantage of that?

This report details one option to consider and explore.

We’ve discovered a unique gold company that stands to benefit from the historic rise in gold prices.

Click here for the full report

*Sponsored content/paid advertisement. This investment involves significant risks. See full disclosure below and detailed explanation of risks and unusual results.

Hot List🔥

GERN – Premarket sales increase of more than 38% following FDA approval of RYTELO™ (imetelstat) for the treatment of adult patients with transfusion-dependent anemia in lower-risk MDS

Geron Corporation (GERN) is a late-stage clinical biopharmaceutical company focused on the development and commercialization of therapeutics for myeloid hematologic malignancies.

All night, The company announced The company announced that RYTELO™ (imetelstat) has received FDA approval for the treatment of adult patients with transfusion-dependent anemia with lower-risk MDS.

Low-risk MDS is a progressive blood cancer with a high unmet need, and many anemic patients become dependent on red blood cell transfusions, which can lead to clinical consequences and reduced quality of life.

“With the approval and availability of RYTELO, we believe eligible patients with low-risk MDS may potentially receive meaningful clinical benefit, particularly potentially freedom from the burden of red blood cell transfusions and symptomatic anemia for 24 weeks or more,” said John A. Scarlett, MD, Chairman and Chief Executive Officer of Geron.

Shares rose more than 38% in premarket trading on the news.

The $5 area is acting as resistance in the pre-market phase and will be an important level to watch.

Further upside objectives include $5.20, $5.30, $5.56 and the pre-market high of $6.14, above which $6.50, $7 and $7.50 are in play.

Below $5, downside targets include $4.50, $4 and the gap-fill target of $3.89.


BCDA – Pre-share price rises over 45% after announcing US patent issued for intramyocardial delivery of cell aggregates to the heart, including a minimally invasive radial artery approach

Biocardia Co., Ltd. (B.C.D.A.) is a clinical-stage regenerative medicine company developing cells and cell-based therapeutics for cardiovascular and pulmonary diseases in the United States.

This morning in the pre-market The company announced The company had been granted a U.S. patent for intramyocardial delivery of cell aggregates to the heart, including a minimally invasive radial artery approach.

The United States Patent Office has granted patent number 11,986,611, entitled “Radial and Transendocardial Delivery Catheters.” The patent term is until 2036.

The present invention relates to medical methods and systems for delivering substances to the heart via the radial artery, suitable for delivering cellular aggregates and other aggregated substances into the heart.

Following the announcement, shares rose more than 45% in premarket trading.

$5.95 will act as support pre-market and will be a key level to watch.

Further upside targets include $6.70, $7 and the pre-market high of $7.41, above which $8, $8.85 and $10 are in play.

Below $5.95, downside objectives include $5.67, $5.20, $4.60 and then a gap fill at $4.37.


Too many choices?

Get the best service at an amazing price

All Access (new!)


VERO – Up over 100% from the previous day after announcing it had restored compliance with Nasdaq

Venus Concept Co., Ltd.Vero) is a medical technology company that develops, commercializes and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services in the United States and around the world.

Outside business hours yesterday, The company announced The company announced that it had once again met Nasdaq’s standards.

Nasdaq staff initially issued a deficiency notice to the Company on May 31, 2023 because stockholders’ equity as reported in the Company’s Quarterly Report on Form 10-Q for the period ended March 31, 2023 was below the minimum amount of $2.5 million required to remain listed.

On May 28, 2024, the Company completed a $35.0 million debt capitalization transaction, which brought the Company into compliance with minimum capital requirements, as confirmed in a Nasdaq notice dated June 4, 2024.

Following the news, shares rose more than 100% in premarket trading.

The $1.20 area will act as support in after-hours and pre-market trading and will be an important level to watch.

Further upside objectives include $1.40, $1.60, $1.80, $2, and the pre-market high of $2.15.

Below $1.20, downside objectives include $1, $0.80 and the gap fill at $0.5867.


Market News 📰


👊 Check if you got my mobile text alerts – Text “RAGE” to 1-(888) 404-5747 To get all the latest information Hot Stock idea Delivered directly to your mobile phone (see1” is at the top!” is written. Don’t miss it!


If you have any questions or concerns about the product, please email us at Support@360wallstreet.io. © Copyright 2022, RagingBull


*Just to be clear, what you’re reading is curated content for which we have received financial compensation (more on that below) to create and deliver. We want to be clear that investing can be like a rollercoaster, as stock prices can fluctuate wildly up and down. Therefore, please consider these significant risks before considering trading any stocks featured here. Be sure to review our full disclosure below for more information on how we are compensated, the risks, and why these results cannot be called “typical.”

Just a quick note about this advertisement you are reading. As I have already stated, we like the company mentioned above and all facts stated above are true to the best of our knowledge, however, we are here to run a business and we received $30,000 (cash) directly from GoldMining Inc prior to writing the content above to help offset the costs of distributing this information and maintaining a large digital audience.

Starting June 3, 2024, we will be launching a 5-day advertising marketing program to help you reach more potential investors. Also, while neither RagingBull nor its owners own shares in the company at this time, they may buy or sell shares in the company in the future. Also, please keep in mind that due to the size of our audience being so large, if even a small number of people decide they want to buy the stock, it may generate interest and cause a temporary spike in the stock price. Also, the opposite may be true at the end of the program, but this is not always the case.

Diving into GoldMining Inc might sound exciting. But remember, it’s like stepping into the wilderness. Remember, trading involves extraordinary risks. This is no small thing. You can lose all the money you invested, so always think carefully about what you’re doing. After all, this is why it’s called trading. We’ve highlighted the good things about this company here, but it’s up to you to do your homework, make your own judgment, and determine your own trading plan, preferably with the help of a professional investment advisor.

Oh, which brings us to another important point. We are not here to tell you (or even recommend) what you should do with your hard-earned money. We are simply sharing our non-expert thoughts by highlighting some of the companies we like that need help telling their stories to a wider audience. Our writing is obviously biased. We are not here to dig up negative things about companies. This is advertising, after all! Also, when we make predictions about the future, take them with a pinch of salt as these are technically known as “forward-looking statements” under securities laws. As with all predictions, they are not firm and are often wrong. And we don’t know what a company’s revenue, business, or stock price will be like tomorrow or a year from now.

Everything you read on this site is intended for your education, information, and entertainment. We believe the information is reliable and accurate, but we cannot guarantee it. Before you begin anything, please consult with a trusted professional – someone who is qualified to give you real advice. To be clear:

Neither Raging Bull nor any of its owners, employees or independent contractors are registered as a securities broker-dealer, broker, investment adviser (IA) or IA representative with the SEC, any state securities regulatory authority or any self-regulatory organization.

That’s the scoop! If you’re intrigued and want to learn more about any of the companies featured here, head over to the SEC website to check out the filings and get the full picture.

You may also like

Leave a Comment

About Us

Investxyon

At InvestXyon, we empower individuals with knowledge for informed investing, financial navigation, and secure futures. Our trusted platform covers investments, stocks, personal finance, retirement, and more.

Feature Posts

Newsletter

Subscribe my Newsletter for new blog posts, tips & new photos. Let's stay updated!